https://orcid.org/0000-0003-1753-6592
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Financial & competing interests disclosure
BH Smith is a member of the Scottish Government’s Short Life Working Group on Prescription Medicine Dependence and Withdrawal and is Chronic Pain Specialty Adviser to the Chief Medical Officer. BH Smith and LA Colvin led the revision of the SIGN Guideline 136 Management of Chronic Pain in 2019 (reference [Citation9]). LA Colvin is a member of the Scottish Government’s Short Life Working Group on Prescription Medicine Dependence and Withdrawal, is Vice Chair of the SIGN Council and is a Member of the MHRA Opioid Expert Working Group. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.